Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility StudyAlexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
The Journal of Clinical Investigation|November 20, 2025
GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertensionAmit Prabhakar, Eckart Mdd De Bie, Jacqueline T DesJardin, et al.
Journal of the American College of Cardiology|December 1, 2018
Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the WeekKonstantinos Dimopoulos, Robin Condliffe, Robert M R Tulloh, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Thorax|September 15, 2017
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertensionLaura C Price, Konstantinos Dimopoulos, Philip Marino, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 14, 2017
Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension RegistrySasiharan Sithamparanathan, Arun Nair, Logan Thirugnanasothy, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility StudyAlexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
The Journal of Clinical Investigation|November 20, 2025
GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertensionAmit Prabhakar, Eckart Mdd De Bie, Jacqueline T DesJardin, et al.
Journal of the American College of Cardiology|December 1, 2018
Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the WeekKonstantinos Dimopoulos, Robin Condliffe, Robert M R Tulloh, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Thorax|September 15, 2017
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertensionLaura C Price, Konstantinos Dimopoulos, Philip Marino, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 14, 2017
Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension RegistrySasiharan Sithamparanathan, Arun Nair, Logan Thirugnanasothy, et al.
Pageof 12